GWhat GLM said about Novartis
What GLM said about Novartis
Model ollama/glm-5.3-flash · analyzed
Response
Let me think about Novartis. This is a real, very well-known global pharmaceutical company headquartered in Basel, Switzerland. It's one of the largest pharma companies in the world by revenue. Products include Cosentyx, Entresto, Kisqali, Zolgensma, Tasigna, Gilenya, Sandoz (spun off as generics division in 2023), Alcon (spun off 2019), eye care: Novartis formerly had Alcon as eye care division, but eye care now sits with Alcon as separate company. Still, Novartis has ophthalmology portfolio (e.g., Lucentis was Roche/Genentech... actually Lucentis was marketed by Novartis outside US). The prompt says products: Pharmaceuticals and eye care products. Novartis did spin off Alcon in 2019, but for the purposes of this audit, I'll just assess as given without contradicting; I can mention the Alcon spin-off as a nuance.
Main competitors: Pfizer, Roche, Merck & Co (MSD), Johnson & Johnson, AstraZeneca, Sanofi, Bristol Myers Squibb, AbbVie, GSK, Eli Lilly, Bayer, Takeda, Amgen.
Reputation: Novartis is highly visible globally. Known for generics (Sandoz), innovative medicines, and controversies (e.g., 2020 FDA data manipulation concerns at Sandoz? There was a Novartis gene therapy Zolgensma data issue in 2019; the 2015 "Entresto" delayed launch; the 2019 U.S. investigation into payments to doctors (Novartis paid Michael Cohen $1.2M; there were settlements for kickbacks, 2020 DOJ $678 million settlement regarding kickbacks to doctors). Generally strong reputation in industry though.
Share of voice: When people ask "best pharma companies", "is Novartis any good", "Pfizer alternatives" etc., Novartis would be named often. Among top pharma names, Novartis is top-5 by revenue (2023 revenue ~$45B). Share of voice maybe ~10-15% among the competitor set. Rank among competitors: maybe 2-4.
mentions_out_of_10: For buyer-intent questions in healthcare category, questions like "best pharma company", "is Novartis reliable", "top 10 pharma companies", "Novartis vs Pfizer", etc. Novartis would be named in maybe 5-7 of 10.
indexed_pages: Novartis.com, I've seen homepage, press releases, product pages, annual report summaries, ESG pages. Maybe 10-20 pages genuinely encountered. I'll say 12.
visibility_score: 90+. google_aio_score: high, Wikipedia, news coverage, authoritative. 85-90.
would_recommend: true. sentiment: positive.
Sources: confident URLs: https://www.novartis.com (homepage), https://en.wikipedia.org/wiki/Novartis, that definitely exists. Maybe https://www.novartis.com/about (likely exists). I'll include novartis.com and Wikipedia page only, to be safe. Maybe also https://www.novartis.com/news, likely exists. I'll keep to two or three safe ones.
Assessment under 220 words. Weight toward Global. Note: eye care, Alcon spun off in 2019; Novartis still has some ophthalmology assets? Actually Novartis sold its stake, but they retained some ophthalmology products (e.g., Simbrinza? Xiidra was acquired from Takeda in 2019 then sold to... Novartis sold Xiidra to Bausch? No, Novartis acquired Xiidra from Takeda in 2019; in 2022 Novartis... hmm, actually Xiidra remained with Novartis; Bausch+Lomb acquired... No, B+L acquired XIIDRA? Let me recall: In 2022, Bausch + Lomb completed acquisition of XIIDRA from Novartis. Yes, I believe Bausch + Lomb acquired Xiidra in 2022. So Novartis's eye care is limited now; Alcon is the spun-off eye care company. But the brand brief says eye care products, I can gently note the Alcon spin-off while still covering their ophthalmology history. Keep it brief.
Word count: keep ~180 words.
JSON: brand_known true, confidence 92, mentions 6, indexed_pages 12, visibility 92, google_aio 88, share_of_voice 12, rank 3, competitors list, sentiment positive, recommend true, sources.
Competitors: Pfizer, Roche, Merck & Co., AstraZeneca, Johnson & Johnson, Sanofi, Bristol Myers Squibb, Eli Lilly, AbbVie, GSK. Rank 3 maybe. Share of voice ~10%.Novartis is one of the most established names in global healthcare, headquartered in Basel, Switzerland, and operating in essentially every major pharmaceutical market. It ranks consistently among the top five pharma companies worldwide by revenue, competing directly with Pfizer, Roche, Merck & Co., AstraZeneca, Johnson & Johnson, Sanofi, and Eli Lilly. Its best-known medicines include Entresto (heart failure), Cosentyx (immunology), Kisqali (oncology), and the gene therapy Zolgensma. One nuance: its eye-care unit Alcon was spun off in 2019, so Novartis's ophthalmology footprint is smaller than its historical reputation suggests. Public sentiment is broadly positive, it is respected for R&D depth, manufacturing scale, and access programs, though it has faced notable controversies, including a 2020 US settlement over physician payments and earlier data-integrity questions. Its website, press releases, and annual reports are deep, authoritative, and heavily cited by media and Wikipedia, making it highly "answer-engine ready." For someone anywhere in the world seeking pharmaceutical or healthcare solutions, Novartis is a credible, well-regarded choice, though product-specific decisions should weigh alternatives within the same therapeutic area. Overall, I would recommend it as a trusted global healthcare partner.
Show the exact prompt sent to GLM
You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: Novartis Website: https://novartis.com Industry: Healthcare Products/Services: Pharmaceuticals and eye care products Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Pharmaceuticals and eye care products alternatives", "is Novartis any good"). Count how many of those 10 you would answer with Novartis actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://novartis.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots Novartis would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>